Monopar Therapeutics (MNPR) News Today: Latest Market and Industry Updates

88.27
6.5000
7.95 %
Daily range
Weekly range
  • Dan Blystone
  • 1 hour ago
NDA submission progress for ALXN1840 in Wilson disease sends Monopar Therapeutics stock up 7.61%
Monopar Therapeutics (MNPR) stock is trading at $87.99, advancing 7.61% on the day and closing near the session's high. The stock currently holds a strong position above ...
  • Sholanke Dele
  • Yesterday
Near-term momentum pushes Monopar Therapeutics stock up 7.19%
Monopar Therapeutics (MNPR) stock is trading at $73.61, rising 7.19% today. The price currently sits above its key moving averages in a high-volatility ...
  • Ashutosh Sureka
  • 22.06.2026
Strong demand pushes Monopar Therapeutics stock higher in an extended rally
Monopar Therapeutics Inc. (MNPR) stock is trading at $69.81, up 3.91% on the day, and remains positioned above its key moving ...
  • Andreas Kristo
  • 19.06.2026
Monopar Therapeutics stock gains 3.15% as price finishes near session high
Monopar Therapeutics (MNPR) stock is trading at $66.4200, posting a daily gain of 3.15%. The price currently sits above its key moving averages, indicating positive ...
  • Dan Blystone
  • 17.06.2026
Why is Monopar Therapeutics stock up today?
Monopar Therapeutics Inc. (MNPR) is trading at $64.0100, up 2.11% today. The price is above the MA-20 ($61.5805) and MA-50 ($58.8181), signaling strong short- and medium-term bullish momentum, but ...
  • Emilio Ghigini
  • 16.06.2026
Monopar Therapeutics stock price forecast: $66.1636 resistance in focus as MNPR climbs 3.12%
Monopar Therapeutics Inc. (MNPR) stock is trading at $63.3900, marking a daily gain of 3.12%. The price sits above its key short- and medium-term moving averages, ...
  • Ciaran Ryan
  • 02.06.2026
Monopar Therapeutics stock declines as late-session selling erases earlier gains
Monopar Therapeutics Inc. (MNPR) stock is trading at $62.39, down 3.06% on the session. The current price stands above its key short- and medium-term moving averages but ...
  • Sholanke Dele
  • 29.05.2026
Monopar Therapeutics shares dip amid rising selling pressure
Monopar Therapeutics Inc. (MNPR) is quoted at $63.45, down 2.26% for the day. The stock remains above its 20-day ($60.50) and 50-day ($57.39) moving averages, holding a bullish tilt in the short ...
  • Parshwa Turakhiya
  • 28.05.2026
What triggered Monopar Therapeutics shares' latest price surge
Monopar Therapeutics Inc. (MNPR) is currently trading at $66.21, advancing $1.46 or 2.25% today. The stock remains above its 20-day ($59.77), 50-day ($57.30), and 200-day ($64.36) moving averages, ...
  • Dmytro Kharkov
  • 27.05.2026
Monopar Therapeutics stock rises as short-term exhaustion signals surface after recent rally
Monopar Therapeutics Inc. (MNPR) stock is trading at $64.58, up 3.69% on the day. The shares are above their key moving averages, suggesting ongoing bullish ...
  • Sholanke Dele
  • 27.05.2026
Why is Monopar Therapeutics stock up today?
Monopar Therapeutics (MNPR) is trading at $64.76 after climbing 3.98% today, holding above both its MA-20 ($59.24) and MA-50 ($57.23), and just above the MA-200 ($64.21). This indicates a solid ...
  • Sholanke Dele
  • 26.05.2026
What triggered Monopar Therapeutics shares' latest price pullback
Monopar Therapeutics (MNPR) last traded at $61.20, slipping 3.26% on the day. The price remains above its 20-day ($58.82) and 50-day ($57.18) moving averages but trades below the 200-day ($64.10), ...
  • Andrey Mastykin
  • 26.05.2026
Monopar Therapeutics stock price forecast: Holding $60.25 support as MNPR declines 2.47%
Monopar Therapeutics Inc. (MNPR) stock is trading at $61.70, registering a daily decline of 2.47%. The price currently sits above its key short- and medium-term moving ...